Literature DB >> 6352652

Ceftazidime in clinical practice - a summary.

S R Norrby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352652     DOI: 10.1093/jac/12.suppl_a.405

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Authors:  A Hedman; Y Adan-Abdi; G Alvan; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

2.  Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation.

Authors:  I W Fong; K B Tomkins
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

3.  Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers.

Authors:  J B Bulitta; C B Landersdorfer; S J Hüttner; G L Drusano; M Kinzig; U Holzgrabe; U Stephan; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

Review 4.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

5.  Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients.

Authors:  M D Reed; C A O'Brien; S C Aronoff; J D Klinger; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.